相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer
Claire E. Fletcher et al.
ONCOGENE (2019)
Genomic correlates of clinical outcome in advanced prostate cancer
Wassim Abida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations
Rinath Jeselsohn et al.
CANCER CELL (2018)
A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer
David Y. Takeda et al.
CELL (2018)
Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with Antiandrogens
E. David Crawford et al.
JOURNAL OF UROLOGY (2018)
Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
Adam Nagy et al.
SCIENTIFIC REPORTS (2018)
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
Pedram Razavi et al.
CANCER CELL (2018)
Alternative splicing in prostate cancer
Alec Paschalis et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Embryonic transcription factor SOX9 drives breast cancer endocrine resistance
Rinath Jeselsohn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer
C. Coarfa et al.
ONCOGENE (2016)
Self-renewal of CD133hi cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer
Pasquale Sansone et al.
NATURE COMMUNICATIONS (2016)
Combination AZD5363 with Enzalutamide Significantly Delays Enzalutamide-resistant Prostate Cancer in Preclinical Models
Paul Toren et al.
EUROPEAN UROLOGY (2015)
Endocrine resistance in breast cancer - An overview and update
Robert Clarke et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Dong Gao et al.
CELL (2014)
Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor-Positive Breast Cancer
Rinath Jeselsohn et al.
CLINICAL CANCER RESEARCH (2014)
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem et al.
SCIENCE (2014)
Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis
Denise A. Yardley et al.
ADVANCES IN THERAPY (2013)
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
Christina Davies et al.
LANCET (2013)
The role of tumour-stromal interactions in modifying drug response: challenges and opportunities
Douglas W. McMillin et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Characterization of metabolic changes associated with the functional development of 3D engineered tissues by non-invasive, dynamic measurement of individual cell redox ratios
Kyle P. Quinn et al.
BIOMATERIALS (2012)
Compartment-specific bioluminescence imaging platform for the high-throughput evaluation of antitumor immune function
Douglas W. McMillin et al.
BLOOD (2012)
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Ravid Straussman et al.
NATURE (2012)
Mechanisms of Endocrine Resistance in Breast Cancer
C. Kent Osborne et al.
ANNUAL REVIEW OF MEDICINE, VOL 62, 2011 (2011)
Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer
Brett S. Carver et al.
CANCER CELL (2011)
Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer
Todd W. Miller et al.
BREAST CANCER RESEARCH (2011)
Hormone Receptor and c-ERBB2 Status in Distant Metastatic and Locally Recurrent Breast Cancer
Pushpalatha K. A. Idirisinghe et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
The role of collagen reorganization on mammary epithelial morphogenesis in a 3D culture model
Eugen Dhimolea et al.
BIOMATERIALS (2010)
Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity
Douglas W. McMillin et al.
NATURE MEDICINE (2010)
Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
Zachary T. Schafer et al.
NATURE (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
Molecular changes in tamoxifen-resistant breast cancer: Relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase
MC Gutierrez et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen
N Shoman et al.
MODERN PATHOLOGY (2005)
Biological characteristics of the pure antiestrogen fulvestrant: overcoming endocrine resistance
M Dowsett et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer
CW Gregory et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients
T Bachelot et al.
BRITISH JOURNAL OF CANCER (2003)
Circulating interleukin-6 predicts survival in patients with metastatic breast cancer
R Salgado et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
The role of apoptosis in creating and maintaining luminal space with normal and oncogene-expressing mammary acini
J Debnath et al.
CELL (2002)
分享论文
